Pharmacists can provide education and services related to key men’s health issues like erectile dysfunction and prostate cancer. This event will overview treatment options for erectile dysfunction, adequate medication use, including non-prescription medicines, and counselling points for these patients. Further, examples of specific campaigns in these areas can help attendees gain insights and skills to better support men in our communities for conditions highlighted by this global campaign.

Moderator:
- Rúben Viegas, Practice Development and Transformation Projects Coordinator, FIP ,The Netherlands

Panellists:
- Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development, FIP, Netherlands
- Regina Ahmed, Guidance Manager, Royal Pharmaceutical Society, UK
- Pablo Caballero Portero, Scientific Dissemination Technician
General Pharmaceutical Council of Spain, Spain
- Raj Vaidya, Community Pharmacist, Hindu Pharmacy, Panaji – Goa, India

FIP is organizing a series of three webinars centred on critical aspects of vaccination. These webinars aim to provide insights into three key topics to advance pharmacy-based vaccination services:
1. The first event is dedicated to addressing vaccine confidence and aims to explore the factors that influence public trust in vaccines and discuss strategies to bolster vaccine acceptance.
2. The second event focuses on preparing for vaccination campaigns during the winter season. This includes discussions on adapting vaccination strategies for seasonal challenges and ensuring the availability of vaccines during this crucial period.
3. The third event focuses on at-risk or vulnerable groups and examines the importance of reaching and safeguarding these populations and explores ways in which pharmacies can play a crucial role in their vaccination.


Moderator:
- Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Panellist:
- Alexandre Chadi, Pharmacist, Montreal University, Canada
- Anna Sangster, Director, Policy, Advocacy and Innovation, International Federation on Ageing, Canada
- Jorge Schlottke, Pharmacist, Confederacion Farmacèutica Argentina (COFA), Argentina
- Leonila Ocampo, President, Asia Pacific Institute for Medication Management, Philippine

One of the key objectives of this webinar series is to harness the insights gained from the panel discussions to inform the development of global guidelines for pharmacy practices related to vaccination. These guidelines will serve as a valuable resource for the international pharmacy community, contributing to more effective and inclusive vaccination efforts worldwide. 

Moderator:
- Dr Luna Bizri, Founder and manager of community pharmacy; Clinical Assistant professor; Adjunct faculty member, Lunapharm pharmacy; Lebanese International University; Lebanese American University, Lebanon

Panellists:
- Prof Lisa Nissen, Director – Health Workforce Optimisation, Centre for the Business and Economics of Health, University of Queensland, Australia
- Dr Eric J. Yager, Chair, Department of Allied Health Sciences; Albany College of Pharmacy and Health Sciences, USA
- Mr Ilan J. Kreiser, Pharmacist - International Liaison Officer, Pharmaceutical Association of Israel, Israel
- Miss Anna van Renen, Research and Policy Officer, International Longevity Centre, UK
- Ms Leticia Caligaris, Pharmacist, Ministery of Defense, Uruguay

FIP is organizing a series of three webinars centred on critical aspects of vaccination. These webinars aim to provide insights into three key topics to advance pharmacy-based vaccination services:

The first event is dedicated to addressing vaccine confidence and aims to explore the factors that influence public trust in vaccines and discuss strategies to bolster vaccine acceptance.

The second event focuses on preparing for vaccination campaigns during the winter season. This includes discussions on adapting vaccination strategies for seasonal challenges and ensuring the availability of vaccines during this crucial period.

The third event focuses on at-risk or vulnerable groups and examines the importance of reaching and safeguarding these populations and explores ways in which pharmacies can play a crucial role in their vaccination.

One of the key objectives of this webinar series is to harness the insights gained from the panel discussions to inform the development of global guidelines for pharmacy practices related to vaccination. These guidelines will serve as a valuable resource for the international pharmacy community, contributing to more effective and inclusive vaccination efforts worldwide.

Moderator:
- Leonila Ocampo, President Asia Pacific Institute for Medication Management, Philippines

Panellists:
- Mary S. Hayney, Professor University of Wisconsin-Madison School of Pharmacy, United States
- Melody L Berg, Editorial Director, Patient Medication Information American Society of Health Systems Pharmacists (ASHP), United States
- Ross McKinnon, Professor College of Medicine and Public Health, Flinders University, Australia

This is the 4th and final episode in the FIP series ‘Vaccination: Benefits beyond specific disease prevention’ which aimed to highlight the extensive advantages of vaccination beyond merely guarding against specific pathogens in older adults.

Parts 1 and 2 focused on the evidence base of indirect benefits of vaccination in areas such as cardiovascular health, diabetes and arthritis in older adults and prolonged immune responses that contribute to sustained health. They also underscored the indispensable role of pharmacists in promoting healthy aging through vaccination.

Este webinar se impartirá en inglés con traducción simultánea al español

Este webinar será apresentado em inglês com tradução simultânea para português

Ce webinaire se déroulera en anglais avec traduction simultanée en français.

このウェビナーは英語で行われ、日本語への同時通訳がつきます。

Moderator:
- Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Netherlands

Panellists:
- Dalia Bajis, FIP Lead for Provision and Partnerships
FIP, The Netherlands
- Eric J. Yager, Associate Professor, Microbiology; Chair, Department of Allied Health Sciences; Director, Pre-Pharmacy Programme; Albany College of Pharmacy and Health Sciences, USA
- Nicola Veronese, Senior Researcher, University of Palermo, Italy

We all know that the primary goal of vaccination is the prevention of pathogen-specific infection. But what about the indirect benefits of vaccines which drive longer-term immune responses that promote long-term health? This webinar – Part 2 - will share contributions, activities, tools that pharmacists lead and utilise to promote healthy aging in the practice setting. The webinar will highlight the varied but crucial role of pharmacists in vaccination, particularly for older adults, and supporting patients' quality of life.

Moderator:
- Dalia Bajis, FIP Lead for Provision and Partnerships - The Netherlands

Facilitator:
- Ozge Ozer, FIP Education and Professional Development Manager - The Netherlands

Panellists:
- Jane Barratt, Secretary General International Federation on Ageing - Canada
- Suzete Costa, Executive Director & Senior Research Director Institute for Evidence-Based Health (ISBE) - Portugal
- Peter Guthrey, Senior Pharmacist- Strategic Policy Pharmaceutical Society of Australia - Australia

We all know that the primary goal of vaccination is the prevention of pathogen-specific infection. But what about the indirect benefits of vaccines which drive longer-term immune responses that promote long-term health? This webinar – Part 1 - will delve into technical and evidence-based insights on positive downstream effects of vaccines in older adults including that on cardiovascular events and diseases, diabetes or arthritis.

Moderator:
- Dalia Bajis, FIP Lead for Provision and Partnerships - The Netherlands

Facilitator:
- Ozge Ozer, FIP Education and Professional Development Manager - The Netherlands

Panellists:
- Mine Durusu Tanriover, Professor of Internal Medicine Hacettepe University - Turkiye
- Eric J. Yager, Associate Professor, Microbiology Chair,
Department of Allied Health Sciences Director, Pre-Pharmacy Programme Albany College of Pharmacy and Health Sciences - USA

Following the pandemic, how to continue to lead the profession globally and support our members during those uncertain times became a core priority for FIP in 2023. As we move on from responding directly to COVID-19 to responding to the aftermath and to readying ourselves for future pandemics and health emergencies, FIP sought to derive key lessons, recommendations and considerations for the future in another report, “Pandemic Preparedness, Response and Recovery: Lessons Learnt for Global Pharmacy” which will be launched at the digital event on August 16.

The event moderators are:
- Sherly Meilianti – FIP Data and Intelligence Specialist
- Farah Aqqad – FIP Regional, Enngagement Support and Development Manager
- Nour Eltahla – FIP Projects coordinator for equity, sustainability policy and development, The Netherlands

The event speakers are:
- Lina Bader – FIP Lead for equity, sustainability policy and development, The Netherlands
- Rao Vadlamudi - Immediate Past President, Indian Pharmaceutical Association (IPA); Professional Secretary, SEARPharm Forum, India
- Jackie Maimin, Chief Executive Officer, Independent Community Pharmacy Association (ICPA); Council member, Pharmaceutical Society of South Africa, South Africa
- Rony Zeenny, Director, Department of Pharmacy, American University of Beirut Medical Centre; INSPECT-LB, Lebanon
- Clare Fitzell, Head of Strategic Policy, Irish Pharmacy Union, Ireland
- Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal
- Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan
- Maria Mendes, Area Manager, Public Health Interventions and Pharmacy Services, National Association of Pharmacies, Portugal
- Sofía Segura, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Moderator:
- Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP) - Netherlands

Facilitator:
- Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development FIP - Netherlands

Panellists:
- Fei Sim, National President Pharmaceutical Society of Australia - Australia
- Daphné Holt, Chair Coalition for Life-course Immunisation - France
- Sarah Sorum, Executive Vice President & CEO Pharmacy Society of Wisconsin, an ASHP state-affiliate - United States
- Catherine Duggan, FIP CEO FIP - The Netherlands

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, healthcare professionals are in contact with multiple patients daily and are therefore at increased risk of contracting and further spreading vaccine-preventable diseases.


Moderator:
- Luís Lourenço, FIP Professional Secretary FIP - Portugal

Panellist:
- Ryan Forrey, Global Clinical Solutions Director BD - U.S.A.
- Jerry Zee, Uniformed Service (Military) Pharmacist U.S. Public Health Service Commissioned Corps - U.S.A.
- Mansi Doshi, Medicines Optimisation Pharmacist and Adjunct Professor, Medicines Optimisation Clinic; PIPR, Parul University (Vadodara); MET, Mumbai University (Mumbai) - India
- Safiye Çağansel, Owner / Pharmacist in Charge, Safiye Çağansel Eczanesi/Pharmacy - Cyprus
- Sherif Guorgu-President FIP Community Canada
- Filipa Alves da Costa, Assistant professor University of Lisbon - Portugal
- Sola Solarin, President FIP Industrial Pharmacy Section - Nigeria
- Susan James, Representatieve FIP Pharmacy Technicians Advisory Committee - Canada
- Rúben Viegas, Practice Development and Transformation Projects Coordinator FIP - The Netherlands

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Moderator:
- Sherif Guorgui, FIP President, Community Pharmacy Section, So-CEO OnPharm-United, Canada

Panellists:
- Sarah Sorum, Executive Vice President & CEO, Pharmacy Society of Wisconsin, an ASHP state-affiliate, United States
- Marisol Flores Campos, Pharmacovigilance Officer, Punto Seguro, Costa Rica
- Pedro Costa e Silva, Manager - Health Services Business Unit, Associação Nacional das Farmácias (ANF), Portugal
- Omaima Arab, Scientific evaluation expert, Saudi Food and Drug Authority, Saudi Arabia

FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

Regulations of pharmacy practice is a critical determinant of pharmacists’ authority to administer and/or prescribe vaccines. FIP data shows that regulations on pharmacy-based vaccination vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies describing how pharmacy-based vaccination, including prescribing, is regulated in their countries.

Moderator:
- Jaime Acosta, FIP-CPS Professional Secretary Community, Pharmacist Farmacia Acosta, Spain

Panellists:
- Hanne Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association, Norway
- Fei Sim, National President Pharmaceutical Society of Australia, Australia
- Luna Bizri, Founder and manager of community pharmacy; Clinical Assistant professor; Adjunct faculty member Lunapharm pharmacy; Lebanese International University; Lebanese American University, Lebanon
- Joyce Mariama Kallon, Team Lead for the supply Chain and logistics vaccine unit Immunisation unit, Sierra Leone

Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.

By the end of the session participants will:
- Understand the specific vaccination needs of several special-risk population groups
- Become familiar with FIP’s resources on vaccination for special-risk groups
- Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups

Moderator:
- Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands

Panellists:
- Jean-Luc Eiselé, CEO World Heart Federation, Switzerland
- Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally)
- Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine
- Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom
- Jane Barratt, Secretary-General International Federation on Ageing, Canada
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
- Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK

Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.

By the end of the session participants will:
- Understand the specific vaccination needs of several special-risk population groups
- Become familiar with FIP’s resources on vaccination for special-risk groups
- Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups

Moderator:
- Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands

Panellists:
- Jean-Luc Eiselé, CEO World Heart Federation, Switzerland
- Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally)
- Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine
- Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom
- Jane Barratt, Secretary-General International Federation on Ageing, Canada
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
- Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK

Remuneration of pharmacy vaccinations is one of the key policy enablers of pharmacy-based vaccinations, and thus life-course immunisation. FIP data shows that remuneration models vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies sharing their remuneration models and journeys for the benefit of policy-enablement everywhere.

This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

Moderator:
- Sari Westermarck, Community pharmacist FIP Community Pharmacy Section, Finland

Panellists:
- Eleftherios Marinos, General Secretary-Federation of Pharmacists’ Cooperatives of Greece, Greece
- Ahmad Al-Rusasi, General manager/Lecturer Alnoor Drug Store, Jordan
- Sham Moodley, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Susan O’Dwyer, Head of Governance and Pharmacy Service, Irish Pharmacy Union, Ireland
- Luís Lourenço, President of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society, Portuguese Pharmaceutical Society, Portugal

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with diabetes have particular vaccination needs that will be highlighted at this event.

By the end of the session participants should be able to:
- Understand the most important vaccines for people living with diabetes
- Recognise the role of pharmacists in promoting vaccination to people living with diabetes
- Discuss strategies for pharmacists to support people living with diabetes with their vaccination needs.

Moderator:
- Astrid Czock, CEO QualiCCare, Switzerland

Panelists:
- Marco Goeijenbier, Medical doctor internal medicine and intensive care, Spaarne Gasthuis Haarlem/Hoofddorp & Erasmus Medical Center Rotterdam, The Netherlands
-  Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist,  University of Huddersfield and Sheffield Teaching Hospitals NHSFT, United Kingdom
- Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine
- Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy, Puerto Rico

Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.

By the end of the session participants should be able to:
• Understand the importance of flu vaccination, especially for vulnerable population groups, like the elderly
• Recognize the need for improving vaccination coverage rates for both the flu and COVID-19.
• Discuss pharmacists’ contribution to flu vaccination strategies.

Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden

Panelists:
- Joshua A. Mott, Technical Advisor for Influenza and Pandemic Preparedness, WHO, Department of Epidemic and Pandemic Preparedness and Prevention, Switzerland
- Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
- Maria Mendes, Area Manager at the Centre for Medicines Information and Health Interventions (CEDIME) at the National Association of Pharmacies, Portugal National Association of Pharmacies, Portugal

Vaccination is one of the most effective measures to prevent disease transmission and help people remain healthy and retain functional ability as they grow older. Adopting a life-course approach to vaccination and providing convenient and accessible vaccination pathways for older adults is essential to achieve high vaccination coverage rates in this particular population group. Pharmacists increasingly offer reliable information and vaccination services around the world. Among the different special-risk population groups, older adults have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:
1. Understand the most important vaccines for older adults
2. Recognise the role of pharmacists in promoting vaccination to the elderly
3. Discuss strategies for the promotion of a life-course approach to vaccination

Moderator:
- Lina Bader, Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Saudi Arabia

Panelists:
- Jean-Pierre MICHEL, Honorary Professor of Medicine University of Geneva, Switzerland
- David Sinclair, Chief Executive ILC. UK
- Jane Barratt, Secretary General International Federation on Ageing, Canada
- Ruggli Martine, President pharmaSuisse, Switzerland

Influenza and COVID-19 can have an important impact in health, productivity and quality of life, especially for vulnerable populations. Likewise, both diseases have vaccines that are available and support a lower risk of transmission of the disease.

Pharmacists can play a major role in reminding people to get vaccinated, building vaccine confidence and supporting their decision making, dispensing vaccines and, in some countries, administering those vaccines.  The coadministration of these vaccines can lead to an efficient and convenient way of improving vaccine uptake against both diseases. Community pharmacies’s accessibility and credibility put them in an ideal situation to provide this important service, thus making a valuable contribution to disease prevention.

This digital event will discuss the importance of promoting the coadministration of COVID-19 and flu vaccines as well as strategies for pharmacies’ involvement.

By the end of the session participants should be able to:

• Understand the benefits of vaccine coadministration
• Recognize the need for vaccination coverage in both flu and COVID-19
• Present the FIP Guideline on this topic

Moderator:

- Daragh Connolly, President, Community Pharmacy Section, Ireland

Panellist:

- Mitchel Rothholz, Immunization Consultant, Three-C Consulting, USA
- Lisa Nissen, Professor (Program Director) – Health Workforce Optimisation, Centre for Business and Economics of Health, (Faculty of Business), Australia
- Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal

This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.

Learning objectives:
1. Improve knowledge of pharmacists on the risks of influenza
2. Exploring pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate within the African region;
3. Showcase country cases from pharmacists across the continent on influenza vaccination, digital vaccination solutions and patient communication on vaccines.

Moderator:
- Arinola Joda, Assistant Secretary and Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria

Guests:
- Cheryl Cohen, Professor & Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases and School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, South Africa
- Gonçalo  Sousa Pinto, Lead for practice development and transformation, FIP, Portugal
- Redouane Soualmi, Chairperson of external relations Algerian Pharmaceutical Federation - Fédération Algérienne de Pharmacie, Algeria
- Merilynn Steenkamp, General Manager Sanofi Vaccines, South Africa
- Wael Ali, General Secretary, EMRPharm Forum , President Egyptian organization of pharmacy, Egypt

Facilitators:
- Nilhan Uzman, Lead for Education and Primary Health Policies, FIP, Turkey
- Alison Etukakpan, Educational Partnership Specialist, FIP, Nigeria

This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.

Learning objectives:
1. Improve knowledge of pharmacists on the risks of influenza
2. Exploring pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate within the African region;
3. Showcase country cases from pharmacists across the continent on influenza vaccination, digital vaccination solutions and patient communication on vaccines.

Moderator:
- Arinola Joda, Assistant Secretary and Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria

Guests:
- Cheryl Cohen, Professor & Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases and School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, South Africa
- Gonçalo  Sousa Pinto, Lead for practice development and transformation, FIP, Portugal
- Redouane Soualmi, Chairperson of external relations Algerian Pharmaceutical Federation - Fédération Algérienne de Pharmacie, Algeria
- Merilynn Steenkamp, General Manager Sanofi Vaccines, South Africa
- Wael Ali, General Secretary, EMRPharm Forum , President Egyptian organization of pharmacy, Egypt

Facilitators:
- Nilhan Uzman, Lead for Education and Primary Health Policies, FIP, Turkey
- Alison Etukakpan, Educational Partnership Specialist, FIP, Nigeria

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
- Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
- Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
- Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
- John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
- Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
- Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
- Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
- John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:

-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
-Understand the main recommended vaccines for people living with chronic respiratory diseases
-Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
-Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists - strategic policy The Pharmaceutical Society of Australia - Australia 

Panelists:
-Ema Paulino,  President  National Association of Pharmacies, Portugal (ANF), Portugal
-Fiona Mosgrove, General Practitioner NHS Grampian, UK
-Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:

-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
-Understand the main recommended vaccines for people living with chronic respiratory diseases
-Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
-Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists - strategic policy The Pharmaceutical Society of Australia - Australia 

Panelists:
-Ema Paulino,  President  National Association of Pharmacies, Portugal (ANF), Portugal
-Fiona Mosgrove, General Practitioner NHS Grampian, UK
-Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain

The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.

Learning objectives:

1. To identify the current role of the pharmacist in tetanus, diphtheria, acellular pertussis booster, COVID vaccination, and meningococcal meningitis vaccination.
2. To explore needs, drivers, and barriers for expanding that role in countries that have regulated pharmacy-based vaccination services.
3. To give examples from countries with pharmacy-based vaccination services  in advocating a broader role for pharmacists in vaccination

Moderators:

- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education, University College London, United Kingdom

- Manjiri Gharat, FIP Vice-President, India 

Panellists:

- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, French Chamber of Pharmacists, France

- Zhi Shan Sujata, Pharmacist, Malaysian Pharmacists Society, Malaysia

-  Sham Moodley, Pharmacist,  Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc, South Africa

- Zeid Kilani, President, Jordan Pharmacists Association, Jordan

- Mas Rahman Roestan, Operational Director of PT Biofarma and Expert Council of Indonesian Pharmacists Association, Indonesian Pharmacists Association, Indonesia

- Irma Beatriz Caponi, Farmacéutica, COFA, Argentina

Facilitators & Speakers:

- Christopher John, FIP Lead for Data and Intelligence, UK 

- Zheng Kang Lum, PhD candidate, National University of Singapore, Singapore

- Allie Jo Shipman, Director, State Policy, National Alliance of State Pharmacy Associations, USA

- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:
- Dr Samira Shammas, FIP Vice president, Jordan
- Jorge Batista, Portuguese Pharmaceutical Society, Portugal

Panelists:
- Dr Nadia Al Mazrouei, President, EMRO Pharm Forum, UAE
- Dr Pascale Salameh, President, Lebanese Order of Pharmacists, Lebanon
- Dr Maha al Jaghbeer, Director of Laboratories directorate, Jordan Food and Drug Administration, Jordan
- Dr Dixon Thomas, Associate Professor - Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University, UAE

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines. 

Learning objectives:

- Identify drivers and barriers related to the regulatory landscape of vaccination in the region

- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination

- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment.

Moderators:

- Manjiri Gharat, FIP Vice President, India
- Al Carter, Executive Director, National Association of Boards of Pharmacy, USA

Panellists:

- Tisara De Silva, President, Pharmaceutical Society of Sri Lanka, Sri Lanka
- Rao V. S. V. Vadlamudi, Professional Secretary, SEARPharm Forum, India
- Nurul Pariang, President, Indonesian Pharmacists Association, Indonesia
- Pramod Yeole, Acting President, Pharmacy Council of India, India

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:

- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment.

Co-moderators:

- Jocelyn Chaibva, Vice president, African Pharmaceutical Forum, Zimbabwe
- Ronald Guse, Chair FIP Regulators Forum, Canada

Panellists:

- Samuel Adekola, Immediate past national chairman & the executive secretary/ program director of the ACPN foundation. Nigeria
- Djamila Reis, CEO, Association of Pharmacists from Portuguese-Speaking Countries, Cape Verde
- Portifa Mwendera, President, Pharmaceutical Society of Zimbabwe, Zimbabwe
- Lucas Nyabero, Interim CEO, Pharmaceutical Society of Kenya, Kenya
- Franck Nana, President, National Council of Pharmacists, Cameroon
- Amath Niang, President, Ordre des Pharmaciens du Sénégal, Sénégal
- Imoiboho Williams, Project Manager, Adverse Events Following Immunization Surveillance Institute of Human Virology, Nigeria
- Redouane Soualmi, Chairperson of External Relations, Algerian Pharmacy Federation, Algeria
- Ezinne Onwuekwe, Vaccine Programme Coordinator, Africa CDC, Ethiopia

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:

- Lars-Åke Söderlund, FIP Vice President, Sweden
- Ronald Guse, Chair of FIP Regulators Forum, Canada

Panelists:
- Michał Byliniak, Vice president, Polish Pharmaceutical Chamber, Poland
- Alain Delgutte, National Board Member, French Chamber of Pharmacists
- Inga Lilý Gunnarsdóttir, President, Pharmaceutical Society of Iceland, Iceland
- Jean-Pierre Michel, Member, European Union of Geriatric Medicine Society. European Interprofessional Council on Ageing, Switzerland
- Ema Paulino, President, National Association of Pharmacies, and member of the National Vaccine Advisory Committee, Portugal
- Roberto Tobia, President, Pharmaceutical Group of the European Union, Italy
- Mariano Votta, President, Active Citizenship Network, Italy

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:
- Magaly Rodríguez de Bittner, Vice president, Pharmaceutical Forum of the Americas, USA
- Anastasia Shiamptanis, Registrar, New Brunswick College of Pharmacists, Canada

Speakers:
- Bertrand Bolduc, President, Order of Pharmacists of Quebec, Canada
- Josélia da Silva Frade, Advisor on Professional Affairs to the president, Federal Council of Pharmacy, Brazil
- Eduardo Savio, President, Pharmaceutical Forum of the Americas, Uruguay
- Sofía Segura, Professor, University of Costa Rica, Costa Rica
- L. J. Tan, Chief Policy and Partnerships Officer, Immunize.org, USA
- Abraham S. Weekes, Council Member, Caribbean Association of Pharmacists, St. Lucia

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:
- Parisa Aslani, FIP Vice President, FIP, Australia
- Ron Guse, Chair FIP Regulators Forum, FIP, Canada

Panelists:
- Amrahi Buang, President, Malaysian Pharmacists Society, Malaysia
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia
- Michael Moore AM PhD, Chair of the WFPHA Global Taskforce on Immunization Adjunct Professor University of Canberra, Australia
- Tony Nelson, Chair of the Steering Committee, Immunisation Partnership Asia Pacific, Hong Kong
- Andi Shirtcliffe, Clinical Chief Advisor Pharmacy, Allied Health and National Immunisation Program. Office of the Chief Clinical Officers, Ministry of Health, New Zealand
- Stephanie Tay, Senior Manager, Chief Pharmacist’s Office, Ministry of Health, Singapore

Malaria is responsible for approximately 400 thousand deaths annually, resulting in an enormous public health burden on many of the tropical and subtropical countries. Although projects are ongoing in WHO, pharmaceutical companies and foundations, basic university-based research is also essential against for treatment and drug resistance in malaria. Engagement of young pharmaceutical scientists in the field is necessary to overcome this situation.

In this event, young PI and early carrier scientists / PhD students related to this scientific subject will be invited as speaker. Dr Eizo Takashima, Ehime University, Japan was invited as a speaker for preliminary lecture, and provide opportunity for young scientists to discuss about the science of malaria.

Learning objectives:

• Describe the development of malaria vaccine candidates.
• Defineseroepidemiology of malaria
• Recognize how early carrier pharmaceutical scientists can be involved in research on drug and vaccine development of malaria.

Moderators:
- Takuya Kumamoto, SIG NM Chair, Prof Hiroshima University, Japan
- Rebecka Isaksson, NGPS SIG Chair, Postdoctoral Research Associate UCL Department of Chemistry, UK

Panelists:
- Dr Eizo Takashima,Associate Professor, Ehime University, Japan
- Dr Wei-Chiao Huang, Post-doc State University of New York at Buffalo, US
- Dr Takaya Sakura, Assistant Professor Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan
- Khalid Garba Mohammed, Lecturer, Bayero University, Kano, Nigeria

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

About the programme:

FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP. 

1) Reconocer la contribución del farmacéutico a las estrategias de vacunación y su relación con los objetivos de desarrollo de la FIP y las prioridades de salud globales.

2) Describir los beneficios, el impacto y las barreras de la inmunización en general y la vacunación en particular, así como experiencias de éxito del farmacéutico como inmunizador a nivel global.

3) Identificar experiencias de éxito del farmacéutico en América Latina en vacunas y su participación en las distintas etapas de la cadena de inmunización-

4) Reconocer las áreas de servicio de la inmunización en el quehacer farmacéutico y las herramientas disponibles para el desarrollo de servicios farmacéuticos de inmunización desde los diferentes ejes de su competencia.

The document "Pharmaceutical services in immunisation: Contributions, experiences and implementation in the Americas region", authored by the Drug Information Centre of the Pharmaceutical Research Institute of the Faculty of Pharmacy of the University of Costa Rica for the Pharmaceutical Forum of the Americas, provides an overview of the involvement of the pharmacy profession in immunisation in Latin America. This introductory webinar will provide an overview of the document’s content and how it relates to the FIP Development Goals. This document is intended to be a tool for the implementation of pharmaceutical services in immunisation in the region, which also complements other reports issued by FIP. The document is available in Spanish, English and Portuguese.

1) Recognise the pharmacist's contribution to immunisation strategies and their relationship to FIP Development Goals and global health priorities.

2) Describe the benefits, impact and barriers of immunisation in general and vaccination in particular, as well as successful experiences of pharmacists as immunisers globally.

3) Identify successful experiences of pharmacists in Latin America in vaccines and their participation in the different stages of the immunisation chain.

4) Recognise the service areas of immunisation in pharmacy and the tools available for the development of pharmaceutical immunisation services from the different areas of their competence.

In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
- Dr. Prosper Hiag – President of the African Pharmaceutical Forum (APF)
- Mrs. Jacqueline Surugue – Chair of the FIP Technology Forum and Hospital Practicioner and Pharmacist, France
-
The speakers at the event are:
- Dr. Daniella Munene – CEO of the Pharmaceutical Society of Kenya
- Dr. Samuel Adekola – Community Pharmacist at His Grace KSP Pharmacy Group and Immediate Past National Chairman of Association of Community Pharmacists of Nigeria
- Dr. Redouane Soualmi - Vice president of international relations of Algerian Pharmaceutical Federation FAP
- Dr. Mariet Eksteen - Professional Development and Support at the Pharmaceutical Society of South Africa

In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Mr. John Jackson - President of the Western Pacific Pharmaceutical Forum, Australia
• Professor Parisa Aslani - Professor in Medicines Use Optimisation at The University of Sydney and FIP Vice President

Panelists:
- Dr. Amrahi Buang - President of the Malaysian Pharmacists Society (MPS)
- Dr. Stephanie Tay - Senior Manager at the Ministry of Health, Singapore
- Mrs. Leonila M. Ocampo - Former President and Member of the Council of Advisers, Philippine Pharmacists’ Association
- Mr. Chris Campbell - General Manager, Policy & Program Delivery and Queensland State Manager at the Pharmaceutical Society of Australia

In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Chinta Abaywardana – Editor, Pharmaceutical Society of Sri Lanka
• Sherly Meilianti – Data and Intelligence Specialist, FIP

The speakers at the event are:
• Rao Vadlamudi – Professional Secretary of SEARPhorum
• Bhojraj Suresh - Pro Chancellor, JSS Academy of Higher Education and Research, India
• Keri Lestari - Lecturer and Pharmacist, Universitas Padjadjaran, Indonesia
• Vindya Pathiraja - General Secretary of the Pharmaceutical Society of Sri Lanka
• Sanjeev Sharma Kattel - Pharmacy Officer/Acting Chief, Department Of Drug Administration, Kathmandu, Nepal

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event will gather different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.

Learning objectives:
1. Understand the role of the various civil society organisations in contributing to increased vaccination coverage.
2. Explore drivers and barriers to diversifying vaccination pathways and providers, allowing for better access to vaccination services.
3. Discuss possible actions and synergies by the different stakeholders in addressing vaccine hesitancy and complacency.

Moderator:
- Catherine Duggan, CEO, FIP

Panellists:
- Jane Barratt , Secretary General, International Federation on Ageing
- Mariano Votta, Director, Active Citizenship Network
- Iryna Vlasenko, Vice president, International Diabetes Federation
- Siân Williams, CEO, International Primary Care Respiratory Group
- Gary Finnegan, Editor, Vaccines Today

In the third of six regions we focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Ema Paulino – Immediate Past Professional Secretary at the International Pharmaceutical Federation (FIP) – Portugal
• Stephanie Kohl - Policy & Advocacy Officer at the European Association of Hospital Pharmacists (EAHP) – Belgium

The speakers at the event are:
- Koen Straetmans - President of the Belgian Pharmaceutical Association (APB)
- Piotr Merks – Adjunct professor at the Faculty of Medicine, Cardinal Stefan Wyszynski University in Warsaw,
- Vibhu Paudyal - Senior Lecturer in Clinical Pharmacy, University of Birmingham and Chair of the Research Committee at the European Society of Clinical Pharmacy (ESCP)
- Monika Derecque-Pois - Director General of the European Healthcare Distribution Association (GIRP)
- Mary Ann Sant Fournier - President of Malta Chamber of Pharmacists

This digital event will discuss how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.

Learning objectives:
1. Discuss the impact of COVID-19 pandemic on the prevalence and evolution of the seasonal influenza around the world.
2. Explore relevance and importance of the influenza vaccination in the coming seasons.
3. Discuss ways to effectively develop confidence in influenza vaccines among the public.
4. Share learnings to address complacency towards the influenza vaccination including harnessing the role of community pharmacists.

Moderator:
-Luís Lourenço, Professional Secretary FIP, Portugal

Panellists:
-Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
-Samantha Marsh, Research fellow University of Auckland, National Institute for Health Innovation, New Zealand
- Dermot Twomey, President Irish Pharmacy Union, Ireland
- Danielle Paes, Chief Pharmacist Officer Canadian Pharmacists’ Association, Canada

In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
- Dr. Ayman Noreddin - EMRO Education Leader and Dean at the College of Pharmacy, Galala University
- Dr. Lina Bader - Lead for Workforce Transformation & Development at FIP

The speakers at the event are:
- Dr. Ziad Nassour - Former President of the Lebanese Order of Pharmacists
- Dr. Madeeha Malik - Director/Professor - Hamdard Institute of Pharmaceutical Sciences
- Dr. Mohammed Al-Nuzili - Governing Board President of Yemen Community Pharmacy Syndicate
- Mr. Ahmed Abdulbary - Senior Regulatory Affairs Pharmacist at the National Health Regulatory Authority
- Prof. Rula Darwish – Professor at the University of Jordan. WDG9 Lead and member of executive committee of FIP academic section, and CPD chair of Jordan Pharmacist Association

En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.

Acerca del programa - El programa digital 2021 de la FIP para transformar la vacunación a nivel mundial, regional y nacional comprende dos series, con un total de 12 eventos que se desarrollarán entre junio y noviembre.

In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region, join us for a true regional perspective.

This event will be moderated by:

• Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay
• Carlos Lacava – Vice President of Uruguayan Association of Chemistry and Pharmacy

The speakers at the event are:

• Dr. Kasey Thomspon - Chief Operating Officer and Senior Vice President of the American Society of Health-System Pharmacists (ASHP), USA
• Martha Rebour - Executive Director at Shot@Life, United Nations Foundation, USA
• Dr. Magaly Rodriguez de Bittner - Vice-President Pharmaceutical Forum of the Americas, USA

Facillitator:

• Rúben Viegas, Practice Development Projects Coordinator FIP, Spain

This event will focus on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists will also discuss working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

About the programme:
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

Moderator:
- Lina Bader - FIP Lead for Workforce Transformation & Development, Saudi Arabia 

Co-Moderator:
- Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay

Panellists:
- Daphne Holt, Chair of Coalition for Life-course Immunisation, France

- Meghna Joshi-Von Heyden, Strategic Development Advisor, Commonwealth Pharmacists Association (CPA), Switzerland

- Suresh Bhojraj, Patron at Indian Association of Colleges of Pharmacy and Pro Chancellor at JSS Academy of Higher Education and Research, Mysuru, India

- Marleen Haems, Director of Professional Management, KOVAG / VAN, Belgium

- Katarina Milosevic Konstadinovic, Community Pharmacist, Chairman of Assembly of Pharmaceutical Chamber of Montenegro, Montenegro

The World Health Organization has listed vaccine hesitancy — concerns related to vaccination or outright refusal to receive vaccines despite availability — as one of the top 10 threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine-preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against COVID-19.

Often “one-size-fits-all” vaccine promotion efforts can backfire when they are presented to individuals who are already sceptical of vaccines. This event will outline evidence-based strategies for developing pharmacist-led interventions which focus on communication with patients in order to build vaccine confidence and improve uptake.

This event will be offred in Eglish with live translation in Spanish and French. 

Learning Objectives:
Understanding vaccine hesitancy and common reasons behind hesitancy; and
Building effective conversation through evidence-based tools.

Moderator:
-Boyan Todorov, President of the FIP Health and Medicines Information Section, President of the FIP Health and Medicines Information Section FIP, Switzerland
Panellists:
- Helen Petousis-Harris, Associate Professor and Vaccinologist University of Auckland, New Zealand
- Amy Chan, Global Lead – Workforce Transformation, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit, University of Auckland, and Auckland District Health Board, New Zealand
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists, Spain

La reticencia a las vacunas fue considerada como una de las 10 principales amenazas para la salud mundial en 2019 por la OMS. La reticencia es uno de los principales factores que impactan en la tasa de cobertura vacunal. La información veraz y rigurosa es una herramienta crucial para combatir la actual infodemia a la que nos enfrentamos. La comunicación directa con los pacientes es una oportunidad clave para que los farmacéuticos desbloqueen los posibles temores a las vacunas y proporcionen mensajes claros y basados en la evidencia para apoyar la adopción de las vacunas. En este evento se presentan estrategias basadas en la evidencia para desarrollar intervenciones dirigidas por los farmacéuticos que se centran en la comunicación con los pacientes con el fin de fomentar la confianza en las vacunas y mejorar su aceptación.

Objetivos de aprendizaje

- Comprender los temores sobre las vacunas a nivel individual

- Discutir posibles herramientas para los farmacéuticos en la construcción de una conversación efectiva .

- Comprender los esfuerzos concretos en las farmacias comunitarias para la promoción de la vacunación a través de estrategias de comunicación eficaces

L'Organisation mondiale de la Santé a classé l'hésitation vaccinale parmi les 10 principales menaces pour la santé mondiale en 2019. Les récentes épidémies de maladies évitables par la vaccination dans de nombreux pays à revenus élevés et l’ampleur de la désinformation au sujet des vaccins récemment approuvés contre la COVID-19 témoignent de cette menace. La réticence est l'un des principaux facteurs qui influent sur les taux de couverture vaccinale. Une information véridique et rigoureuse est un outil essentiel pour lutter contre l'infodémie actuelle à laquelle nous sommes confrontés. La communication directe avec les patients est une occasion clé pour les pharmaciens de révéler les craintes potentielles liées aux vaccins et de fournir des messages clairs, fondés sur des preuves, pour soutenir l'adoption des vaccins. Cet événement présente des stratégies fondées sur des données probantes pour développer des interventions dirigées par des pharmaciens et axées sur la communication avec les patients afin de renforcer la confiance dans les vaccins et d'améliorer leur utilisation.

Objectifs d'apprentissage

- Comprendre les craintes que suscitent les vaccins au niveau individuel.

- Discutez des outils possibles pour les pharmaciens afin d'établir une conversation efficace.

- Comprendre les efforts concrets des pharmacies communautaires pour promouvoir la vaccination par des stratégies de communication efficaces.

This event will have a focus on the issues around health literacy and access to information. The societal influences on the ‘’infodemic’’ will be laid out, also the role of health care professionals, health workers and be vaccine hesitant people. We will consider all the policy elements that need to be addressed to overcome this, identifying tools to overcome these issues from a range of angles and the role pharmacy can play.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

This event will be moderated by Professor Timothy Chen, President of the Social and Administrative Pharmacy Section at FIP and the Head of Pharmacy Practice and Health Services Research at The University of Sydney.

Moderator:
Timothy F Chen, Head of Pharmacy Practice and Health Services Research, The University of Sydney

Speakers:
• Mujahidhussein G Valji - Chief Pharmacist, Aga Khan Health Services, Tanzania
• Dr. Régis Vaillancourt - Pharmacy Consultant, Canada
• Dr. Fiona Stanaway - Senior Lecturer in Clinical Epidemiology, School of Public Health, University of Health, Australia
• Hannelie Meyer - Professor in the School of Pharmacy, Sefako Makgatho Health Sciences University, and Head of the South African Vaccination and Immunisation Centre (SAVIC)

Episode 3 examines inequities in gender access to vaccines to inform pharmacy policy. Various angles to vaccinations and the gender will be discussed including general gender access, terms of empowering women as caregivers to support vaccinations, the impact of COVID-19 on gender inequity, and the issues around gender inequity in the workforce (which is especially important to discuss in 2020 Year of the Health Worker).

The World Health Organization lists vaccine hesitancy—concerns related to vaccination or outright refusal to receive vaccines despite availability—as one of the top ten threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against novel Sars-Cov-2 virus.

Often times, “one-size-fits-all” vaccine promotion efforts can backfire when presented to individuals who are already sceptical of vaccines. This event will outline evidenced-based strategies for developing pharmacy-led immunization campaigns which communicate the value of vaccines to specific patient groups in order to build vaccine confidence and improve uptake.

Delivered in English with live translation in French and Spanish languages. 

Learning Objectives:
1. Understanding vaccine hesitancy and common reasons behind hesitancy
2. Developing a robust immunization campaign: steps and essential components
3. Assessing the success of immunization campaigns and importance of continuing advocacy

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Episode 2 takes a life-course approach to discussing vaccination. The panelists will focus on age and explore vaccines equity and access through life’s ages and stages – from childhood (including pregnancy) to later adulthood – from a pharmacy perspective. They will focus on setting out the policy issues and immediate next steps, determining what pharmacy needs to do to singularly affect the most change in this area.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

About this series – The first of the two series comprises 5 episodes which include the opening event alongside 4 other events which explore equity in vaccinations across the different angles of age, gender, literacy & education, and interprofessional unity & collaboration.

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, FIP

Guest:
- Jane Barratt, Secretary-General International Federation on Ageing

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. As such, FIP considers that it is essential to promote dialogue and understanding around these perceptions among healthcare professionals’ organisations at the international level, so that these can be cascaded to the regional, country and local levels.
After this webinar the participants should have a better understanding of the following topics:
1. The role of the various health professions in contributing to increased vaccination coverage
2. Drivers and barriers to diversifying vaccination pathways and providers.
3. Possible actions by the different health professions in addressing vaccine hesitancy and complacency.
4. Collaboration and autonomy of the various healthcare professionals in delivering vaccinations.

Moderator:
Jane Barratt, Secretary-General International Federation on Ageing

Panellists:
-David O. Barbe, President World Medical Association
-Howard Catton, Chief Executive Officer International Council of Nurses
- Jonathon Kruger, CEO World Physiotherapy
- Catherine Duggan, CEO International Pharmaceutical Federation (FIP)
- Enzo Bondioni, Executive Director, FDI World Dental Federation

Episode 1, the digital programme’s Opening Event, will set the stage for the entire programme. Together we will revisit the key outcomes of the Transforming Vaccination 2020 programme, specifically focusing on the outcomes relating to shaping policy around equity, access and sustainability and how they are shaping the FIP vaccination agenda for 2021. We will also describe this year’s programme, outline its key aims and objectives as well as outcomes. This special programme opener is for anyone invested in transforming and shaping vaccination in pharmacy!

Moderators:
- Lina Bader, Lead for Workforce Transformation & Development, International Pharmaceutical Federation -Saudi Arabia
- Farah Aqqad, Regional Engagement and Project Coordinator International Pharmaceutical Federation (FIP) - Jordan

Panellists:
- Catherine Duggan, CEO International Pharmaceutical Federation (FIP) - The Netherlands
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation International Pharmaceutical
Federation (FIP) - Spain
- G. Sumalatha, Executive Committee Member SEARPharm Forum - India
- Prosper Hiag, President African Pharmaceutical Forum (APF) - Cameroon
- John Jackson, President Western Pacific Pharmaceutical Forum - Australia
- Nadia Al Mazrouei, President EMROPharm Forum, Academic &Healthcare consultant - UAE

FIP’s Regulators’ Forum will present a new regulatory vaccination preparedness self-assessment tool and risk assessment. Foundational regulatory needs will be presented to ensure oversight, quality assurance and public protection as the scope of pharmacist’s patient care is expanded to include prescribing, vaccination and testing in order to address population health needs during a pandemic. A brief overview of the data collected by FIP on the role of pharmacists in vaccinations and other FIP documents will also be presented.

Learning Objectives:
- Awareness of the global variation of the pharmacist scope of practice reported FIP global survey
- The valuable and available resource of information contained in the FIP documents regarding pharmacist vaccination and expanded scope of practice.
- Foundational regulatory needs for public protection when expanding the pharmacists’ scope of practice.
- Availability of a vaccination preparedness self-assessment tool.

Moderators:
- Ronald Guse, Chair, FIP Regulators Forum - Canada
- Catherine Duggan, CEO, FIP - The Netherlands

Panellists:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, FIP - The Netherlands
- Lemrey “Al” Carter, Executive Director, National Association of Boards of Pharmacy - USA

Although pharmacists have administered vaccines in several countries for years, this role is still new or even unknown to the profession in many parts of the world. As a role that involves direct contact with the patient and the administration of a product by injection, it may still generate some concerns among pharmacists with regards to the administration procedure, common errors and the management of anaphylactic reactions. This webinar will describe such procedures and address common questions and concerns.

After this webinar the participants should have a better understanding of the following topics:

- Vaccine administration routes and procedures.
- Common errors that may be committed during vaccine administration and how to avoid them.
- Prevention and management of adverse reactions, including anaphylactic shock.

Moderator:

- Marwan Akel, Chairperson Pharmacy Practice Department, Lebanese International University - Lebanon

Panellists:

- Lisa Nissen, Professor and Head of the School of Clinical Sciences, Queensland University of Technology - Australia
- Maria Mendes, Area Manager at the Centre for Medicines Information & Health Interventions (CEDIME) at the National Association of Pharmacies - Portugal

This global virtual Summit – the programme finale – is a high-level event in which we will recap the primary outcomes of the 24-event digital series. Together, we will adopt the FIP Commitment to Action on Vaccination in Pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

This roundtable event follows 6 regional events – episodes 3.1 to 3.6 of the programme – which dissected priorties, needs and barriers across the world’s six regions. We now bring back the key outcomes from the six regional discussions int one roundtable to identify common priorities for action to transform vaccination. Each regional perspective will be represented by the panelists, alongside other leaders and stakeholders.

Objective
To understand the commonalities of different jurisdictions in delivering on the Transformation of Vaccination Globally and Regionally

Moderator:
- Ronald Guse, Chair, FIP Regulators' Forum, National Association of Boards of Pharmacy, Canadian Consultant - Canada

Co-moderator:
- Lina Bader, Lead for Workforce Transformation & Development, Programme Lead – Transforming Vaccination Globally & Regionally, International Pharmaceutical Federation (FIP) - Saudi Arabia

Speakers:
- Stephanie Kohl, Policy & Advocacy Officer, European Association of Hospital Pharmacists - Belgium
- G. Sumalatha, Executive Committee Member, SEARPharm Forum - India
- Nadia Al Mazrouei, President, EMROPharm Forum, Academic &Healthcare consultant - UAE
- Prosper Hiag, President, African Pharmaceutical Forum - Cameroon
- John Jackson, President, Western Pacific Pharmaceutical Forum - Australia
- Eduardo Savio, President, Pharmaceutical Forum of the Americas - Uruguay

Event 3.6 focuses on the regional needs and drivers for transforming vaccination in the Americas region. This involves discussing the progress made in countries in the Americas with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation.

Moderator:
- Nuria Montero Chinchilla, Directora de Práctica Farmacéutica, Foro Farmacéutico de las Américas - Costa Rica
- Carlos Lacava, Vice-presidente, Federación Internacional Farmacéutica (FIP) - Uruguay

Facilitator:
- Gonçalo Sousa Pinto, Director de Desarrollo y Transformación de la Práctica, Federación Internacional Farmacéutica (FIP) - España

Speakers:
- Ligia Álvarez, Presidente, Colegio Nacional de Farmacéuticos - Panamá
- Maria Isabel Reinoso, Presidente, Confederacion Farmaceutica Argentina - Argentina
- Luis Baez, Presidente, Asociación de Químicos Farmacéuticos del Paraguay-AQUIMFARP - Paraguay
- Marco Oswaldo Padilla Puruncajas, Presidente, Colegio de Químicos, Bioquímicos y Farmacéuticos de Pichincha, Ecuador
- Mariela Méndez Ferreira, Presidente, Asociación de Química y Farmacia del Uruguay- Uruguay

In the fifth of six regions we dissect, event 3.5 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves discussing the progress made in Africa with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from Africa join us for a true regional perspective.

Objective
To understand the African perspective in delivering on the Transformation of Vaccination Globally and Regionally

Moderators:
Prosper Hiag, President, African Pharmaceutical Forum (APF), Member of the Council of the FIP – Cameroon
Jacqueline Surugue, Vice President – International Pharmaceutical Federation (FIP)- Past President of the Hospital Section Chair of the FIP Pharmaceutical Technology Forum, Hospital Pharmacist, Centre Hospitalier Georges Renon – France

Facilitator:
Nilhan Uzman, Lead for Education Policy and Implementation, International Pharmaceutical Federation (FIP) – Turkey

Speakers:
Yvonne Yirenkyiwaa Esseku, Vice President, Pharmaceutical Society of Ghana – Ghana
Redouane Soualmi, General Secretary, Algerian Pharmaceutical Federation – Fédération Algérienne de Pharmacie – Algeria
Nahil Dave, Superintendent Pharmacist, Pharmaceutical Society of Kenya – Kenya

In the fourth of six regions we dissect, event 3.4 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific. This involves discussing the progress made in Western Pacific countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the Western Pacific join us for a true regional perspective.

Objective
To understand the Western Pacific perspective in delivering on the Transformation of Vaccination Globally and Regionally

Moderators:
John Jackson, President, Western Pacific Pharmaceutical Forum – Australia
Parisa Aslani, Vice-President, International Pharmaceutical Federation (FIP) – Australia

Facilitator:
Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation (FIP)

Speakers:
Gilda Sebua-Saljay, President, Philippine Pharmacists Association – Philippine
Peter Guthrey, Senior Pharmacist- Strategic Policy, Pharmaceutical Society of Australia – Australia
Scarlett Pong, President, The Pharmaceutical Society of Hong Kong (PSHK) – Hong Kong

In the third of six regions we dissect, event 3.3 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region (EMR). This involves discussing the progress made in EMR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the EMR join us for a true regional perspective.

Objective:
To understand the Eastern Mediterranean perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- Nadia Al Mazrouei, President, EMROPharm Forum - UAE
- Samira Shammas, Vice President, International Pharmaceutical Federation (FIP) - Jordan

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Ziad Nassour, President, Lebanese Order of Pharmacists - Lebanon
- Adi Al-Nuseirat, Technical Officer, WHO Eastern Mediterranean Regional Office - Egypt
- Zeid Kilani, President, Jordanian Pharmacists Association - Jordan
- Alaa Hayallah, President, Pharmacists Syndicate in Assiut - Egypt
- Faraz Ashraf, Deputy director pharmacy / Joint Secretary of Pakistan Pharmacists Association, The children's hospital and the institute of child health, Lahore - Pakistan
- Mohammed Al-Nuzili, Governing Board President, Yemen Community Pharmacy Syndicate - Yemen

In the second of six regions we dissect, event 3.2 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region (SEAR). This involves discussing the progress made in SEAR countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the SEAR join us for a true regional perspective.

Objective:
To understand the South East Asian perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- G. Sumalatha, Executive Committee Member, SEARPharm Forum - India
- Ashok Soni, Vice President, International Pharmaceutical Federation (FIP) - UK

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Rao Vadlamudi, Immediate Past President, Indian Pharmaceutical Association (IPA) - India
- Lalith Senarathna, Senior Lecturer, Rajarata University of Sri Lanka - Sri Lanka
- Manisha Shridhar, Regional Advisor, WHO Regional Office for South-East Asia - India
- Kampanart Huanbutta, Assistant Dean, Faculty of Pharmacy, Burapha University - Thailand

In the first of six regions we dissect, event 3.1 focuses on the regional needs and drivers for transforming vaccination in Europe. This involves discussing the progress made in European countries with regards to pharmacist vaccination, the quality and universal access to vaccinations. We also discuss barriers and challenges and regional needs for future transformation. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

Objective:
To understand the European perspective in delivering on the Transformation of Vaccination Globally and Regionally

Funded by Charitable Donation from Pfizer

Moderators:
- Stephanie Kohl, Policy & Advocacy Officer, European Association of Hospital Pharmacists (EAHP) - Belgium
- Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal

Facilitator:
- Lina Bader, Lead for Workforce Transformation and Development, International Pharmaceutical Federation (FIP) - The Netherlands

Speakers:
- Alain Delgutte, President-elect, Pharmaceutical Group of the European Union (PGEU) - Belgium
- Monika Derecque-Pois, Director General, European Healthcare Distribution Association (GIRP) - Belgium
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists - Malta
- Niyazi Cakmak, Technical Officer, WHO Regional Office for Europe - Denmark
- Lieven Lieven Zwaenepoel, Past President, Belgian Pharmaceutical Association (APB) Belgium
- Mesut Sancar, Representative, Turkish Pharmacists' Association (TPA) - Turkey

This event will discuss how the quality, efficacy and safety of vaccines are built into their development and manufacturing processes, including the clinical research they undergo and the strict regulatory assessment that precedes their marketing authorization. In addition, speakers will discuss how to make such processes understood and well-known by the public in a transparent and clear manner, in order to build confidence in vaccines and address the grave problem of vaccine hesitancy and anti-vaccines movements, i.e., the refusal to get vaccinated despite the availability of vaccines.

Learning Objectives:
After this webinar the participants should have a better understanding of the following topics:
1. Vaccine quality and safety assurance.
2. Vaccine hesitancy and how to address it through transparent and evidence-based arguments, and positive examples of the value of vaccines.
3. The role of pharmacists in building vaccine confidence.

Programme: Communicating vaccine safety, building vaccine confidence
Moderator:
- Giovanni Pauletti, FIP’s Scientific Secretary
Chair, Department of Pharmaceutical & Administrative Sciences, St. Louis College of Pharmacy - USA

Speakers:
- Alberta Di Pasquale, Director, Global Medical Affairs Vaccine Science and Medical Education Lead, GSK - Belgium
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists – Spain

In this episode – “Setting Transformation Goals for Vaccination Globally” – is a roundtable discussion that focuses on the role of the FIP Development Goals in the transformation of pharmacist vaccination globally and regionally. The discussion will focus on the development of transformative goals and how these goals will be used to deliver pharmacist vaccinators in all jurisdictions, resulting in increased vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To summarise and discuss the impact of FIP Development Goals in the Transformation of Vaccination Globally and Regionally.

Moderators:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation - The Netherlands
- Carlene Ngoma, Global Lead for Equity and FIP Program co-ordinator for FIP transformation of Vaccination Globally and Regionally, International Pharmaceutical Federation - Australia

Speakers:
- Arit Udoh, Senior Clinical Project Manager, University of Birmingham - UK
- Marwan Akel, Chairperson Pharmacy Practice Department, Lebanese International University - Lebanon
- Chima Amadi, Education and Training Personnel, Pharmacists’ Council Nigeria - Nigeria
- Catherine Duggan, Chief Executive Officer, International Pharmaceutical Federation - The Netherlands
- Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health, University of KwaZulu-Natal - South Africa
- Lars-Åke Söderlund, President the Community Pharmacy Section, International Pharmaceutical Federation - Sweden

In this episode – “Pharmacist Vaccinators and Patient Safety” – is an interview format that focuses on the FIP Development Goal 19: Patient Safety from the perspective of vaccination by a pharmacist. The role of pharmacists in delivering safe vaccinations; participation in vaccination monitoring and adverse event reporting, and the role of improving vaccination rates as a method of reducing overall harm caused by preventable disease.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 19: Patient Safety in the Transformation of Vaccination Globally and Regionally

Moderator:
Lars-Åke Söderlund, Executive Advisor, Apoteket AB - Sweden

Speakers:
Ramesh Walpola, Lecturer, School of Population Health, UNSW Sydney - Australia
John Hertig, Associate Professor, Butler University - USA
Ema Paulino, Professional Secretary, International Pharmaceutical Federation (FIP) - Portugal
Alpana Mair, Head of Prescribing and Therapeutics for Scottish Government, coordinating delivery of Governments work programme and advising Ministers on Quality, safety and effectiveness of Prescribing, Scottish Government - UK

In this episode – “Pharmacist Vaccinators as a way to improve access to medicines” – is an interview format that focuses on the FIP Development Goal 18: Access to Medicines and Services from the perspective of vaccination by a pharmacist. The role of pharmacists in ensuring that vaccinations are widely and easily accessible by all people in all areas of the world, and the expertise of pharmacists in delivering the logistics and services needed to increase vaccination rates.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 18: Access to Medicines and Services in the Transformation of Vaccination Globally and Regionally

Moderator:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Panellists:
Jane Barratt, Secretary General, International Federation on Ageing - Canada
Alexandra Ruth, Doctoral Student, Johns Hopkins Bloomberg School of Public Health - USA

In this episode – “Pharmacist Vaccinators and Antimicrobial Stewardship” – is an interview format that focuses on the FIP Development Goal 17: Antimicrobial Stewardship from the perspective of vaccination by a pharmacist. The role of vaccination in antimicrobial stewardship, preserving antimicrobial effectiveness, preventing antimicrobial resistance, and the promise of addressing these issues that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 17: Antimicrobial Stewardship in the Transformation of Vaccination Globally and Regionally

Moderator:
Sabiha Essack, South African Research Chair in Antibiotic Resistance & One Health Chair: Global Respiratory Infection Partnership, University of KwaZulu-Natal - South Africa

Speakers:
Alfonso Pereira Céspedes, Pharmacist, University of Costa Rica - Costa Rica
Manjiri Gharat, Vice President, Indian Pharmaceutical Association - India
Philip Howard, Consultant Pharmacist, Leeds Teaching Hospitals NHS Trust - UK
Debra Goff, The Ohio State University Medical Center - USA

In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA

In this episode, “Removing Policy Barriers to Pharmacist Vaccination” – is an interview format that focuses on the FIP Development Goal 13: Policy Development from the perspective of vaccination by a pharmacist. We discuss the process of policy development, identification of barriers, and engagement with stakeholders to ensure that pharmacist vaccination is accessible to all people in all settings where pharmacists work.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Outcomes
To understand the impact of FIP Development Goal 13: Policy Development in the Transformation of Vaccination Globally and Regionally

Moderators:
Ellen Schafheutle, Professor of Pharmacy Policy and Practice Centre for Pharmacy Workforce Studies, The University of Manchester - United Kingdom
Chima Amadi, Education and Training Personnel Pharmacists’ Council Nigeria - Nigeria

Panellists:
1. Walter da Silva João, President Brazilian Federal Council of Pharmacy - Brazil
2. Howard Rice, Hon. President & International Liaison Officer Pharmaceutical Association of Israel - Israel
3. Shane Jackson, Community and Consultant Pharmacist - Pharmaceutical Society of Australia - Australia

In this episode, “Empowering Pharmacists to Deliver Vaccination in all Settings” – is an interview format that focuses on the FIP Development Goal 7: Advanced Integrated Services from the perspective of vaccination by pharmacist. We discuss change management principles in the context of integrating advanced practice services into every day practice, ensuring that vaccination by pharmacists in all settings and jurisdictions is consistent with best evidence and practice guidelines. Where a pharmacist is present in all settings, vaccinations can be provided. Ensuring collaborative work and shared documentation with all healthcare professionals to ensure it is an integrated service.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Objective
Identifying mechanisms for transforming vaccination using FIP DG7: Advancing integrated services

Moderator:
Marwan Akel, Chairperson Pharmacy Practice Department Lebanese International University - Lebanon

Panellists:
1.Barbel Holbein, Lecturer and Researcher University of Bremen; University of applied sciences-Baden Württemberg - Germany
2.Sofía Segura, Professor University of Costa Rica and College of Pharmacists of Costa Rica - Costa Rica
3. Pamela Logan, Director of Pharmacy Services Irish Pharmacy Union - Ireland
4. Scarlett Pong, President of The Pharmaceutical Society of Hong Kong - Hong Kong

In this episode – “Vaccination: From Specialist Practice to Everyday Practice” – is an interview format that focuses on the FIP Development Goal 4: Advanced & Specialist Development from the perspective of vaccination by a pharmacist. We discuss the process required to take vaccination by pharmacists from a specialized field that few pharmacists deliver in some jurisdictions, to a standard part of pharmacists’ care in all settings and locations.

Power Point slides

Moderators:
Arit Udoh, Clinical Project Manager University of Birmingham-United Kingdom
Desak Ketut Ernawati, Academic and Researcher Faculty of Medicine Universitas Udayana-Indonesia

Speakers:
1. Hanne Merete Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association - Norway
2. Andi Shirtcliffe, Clinical Chief Advisor – Pharmacy, Quality Use of Medicines, Allied Health Ministry of Health - New Zealand
3. Greg Eberhart, Registrar Alberta College of Pharmacy-Canada
4. Jorge Batista, International Affairs Lead Portuguese Pharmaceutical Society - Portugal

La grippe saisonnière représente une charge de morbidité importante pour le système de santé et un risque pour plusieurs groupes de population, notamment les personnes âgées, les personnes souffrant d'affections sous-jacentes, les femmes enceintes et d'autres.
La menace d'une deuxième épidémie de COVID-19 est très réelle, et le risque que les deux virus entraînent une morbidité et une mortalité combinées ne peut être négligé.

Ce panel discutera comment plusieurs pays francophones relèvent ce défi grâce à la vaccination en pharmacie, et comment les pharmaciens peuvent contribuer à améliorer la couverture vaccinale contre la grippe et contre d’autres maladies évitables par la vaccination tout au long de la vie. Le panel discutera également du rôle du pharmacien d’officine dans la réponse aux doutes et aux mythes sur les vaccins. Il abordera également la question de la nécessaire collaboration interprofessionnelle et de sa valeur ajoutée pour les patients et pour la société, la vaccination en pharmacie représentant une extension et non un déplacement de l’accès à la vaccination.

Après ce webinaire, les participants devraient comprendre :
1. L'impact de la vaccination en pharmacie sur les taux de couverture vaccinale ;
2. Pourquoi les populations vulnérables (personnes âgées, patients chroniques et professionnels de la santé) devraient être vaccinées contre la grippe, en particulier dans le contexte de la pandémie;
3. Le rôle des pharmaciens dans l’amélioration de la couverture vaccinale tout au long de la vie contre différentes maladies;
4. Les stratégies adoptées par certains pays francophones pour augmenter la couverture vaccinale contre la grippe via les pharmacies et comment ils ont surmonté l'opposition liée aux corporations par des preuves et des approches collaboratives.

Scope: Transforming Vaccination with the FIP Development Goals: Brining practice, science and workforce together

What were the key insights and summaries from each of the events so far?

What was the one key message you gathered from that presentation, what was the main need identified from the presentation?

What is one key change you think that could be implemented to address this change?

Moderators:
Dominique Jordan, FIP President - Switzerland
Catherine Duggan, FIP CEO - the Netherlands

Panellists:
1. Ema Paulino, FIP Professional Secretary - Portugal
2. Paul Sinclair, Community Pharmacist Chair Board of Pharmaceutical Practice - Australia
3. Giovanni Pauletti, FIP Scientific Secretary - USA
4. Ross MacKinnon, Chair of FIP Board of Pharmaceutical Science, FIP - Australia
5. Ralph Altiere, Chair of FIP Education FIP - USA
6. Ian Bates, Chair of pharmacy education, UCL - UK
7. Allie Jo, Director, State Policy National Alliance of State Pharmacy Associations -
USA

Presentation slides are available here.

FIP is launching a transforming vaccination globally and regionally 24 part series. In series 1, we are running 8 episodes that focus on identifying the needs for vaccine transformation across science, practice and workforce and education. In today’s event, part 6, we will be focusing on practice needs and our guest panel will discuss how the workforce and education can help transform vaccination globally and regionally discussing initial education, continuing education and the potential for progress in these areas.

Scope: Workforce & education needs: Focus on initial education

What is education currently like in your country with regards to vaccination for both initial education and continuing education?

How can this be improved?

Has education kept up with the advances in pharmacy services development?

Moderators:
Ralph Altiere, Dean University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - USA
Ian Bates, Chair of pharmacy education UCL - UK

Panellists:

1. Lisa Nissen, Head, School of Clinical Sciences Queensland University of Technology -Australia
2. João Guedes, President, IPSF, International Pharmaceutical Students' Federation - Portugal
3. Romeo C. Ongpoy, Jr., Dean School of Pharmacy at Romeo Ongpoy - Philippines

Moderator

• Catherine Duggan– (FIP, The Netherlands)

Speakers

• Ronald T. Piervincenzi, CEO, United States Pharmacopeia
• Ross Mckinnon – FIP Chair of Board of Pharmaceutical Sciences (College of Medicine and Public Health, Australia)
• Giovanni Pauletti – FIP Scientific Secretary (St. Louis College of Pharmacy, USA)

Moderator: Ross McKinnon (College of Medicine and Public Health, Australia)

Speakers: Colin Pouton (Monash Institute of Pharmaceutical Sciences, Australia), Nikolai Petrovsky, Founder and CEO, Vaxine (Australia)

Moderator: Ema Paulino

Panelists: Paul Sinclair, Yong Pei Chean, Faraz Ashraf, Manjiri Gharat, Indre Treciokiene, Samira Shammas

Slides

Moderator: Prof Ashok Soni

Panellists: Dr Michael Moore, Prof. Justin Ortiz

Moderator: Ema Paulino

Panellists: Bram Palache, Matthew Downham, Hanne Andresen, 

Moderator: Catherine Duggan

Panellists: Dominique Jordan, Sónia Queirós, Ann Lindstrand, Duarte Santos, Jane Barratt, Radu Costin Ganescu

The presentation is available here.

The presentation is available here.

The presentation is available here.

The presentation is available here.